Literature DB >> 26660347

Defining criteria for disease activity states in juvenile idiopathic arthritis.

Alessandro Consolaro1, Angelo Ravelli2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26660347     DOI： 10.1093/rheumatology/kev414

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  Paediatric rheumatic disease: What is the best definition of clinical remission in JIA?

Authors:  Gabriella Giancane; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2017-06-29       Impact factor: 20.543

Review 2.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

3.  The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).

Authors:  Miriam Listing; Kirsten Mönkemöller; Ina Liedmann; Martina Niewerth; Claudia Sengler; Joachim Listing; Dirk Foell; Arnd Heiligenhaus; Ariane Klein; Gerd Horneff; Gerd Ganser; Johannes-Peter Haas; Jens Klotsche; Kirsten Minden
Journal:  Arthritis Res Ther       Date:  2018-05-30       Impact factor: 5.156

Review 4.  The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.

Authors:  Nataša Toplak; Štefan Blazina; Tadej Avčin
Journal:  Drug Des Devel Ther       Date:  2018-06-08       Impact factor: 4.162

5.  Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.

Authors:  Christoph Tappeiner; Jens Klotsche; Claudia Sengler; Martina Niewerth; Ina Liedmann; Karoline Walscheid; Miha Lavric; Dirk Foell; Kirsten Minden; Arnd Heiligenhaus
Journal:  Arthritis Rheumatol       Date:  2018-08-21       Impact factor: 10.995

6.  Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.

Authors:  Nicolino Ruperto; Hermine I Brunner; César Pacheco-Tena; Ingrid Louw; Gabriel Vega-Cornejo; Alberto J Spindler; Daniel J Kingsbury; Heinrike Schmeling; Arturo Borzutzky; Rubén Cuttica; C J Inman; Victor Malievskiy; Christiaan Scott; Vladimir Keltsev; Maria Teresa Terreri; Diego Oscar Viola; Ricardo M Xavier; Taciana A Pedrosa Fernandes; María Del Rocío Maldonado Velázquez; Michael Henrickson; Michael B Clark; Karen A Bensley; Xiaoming Li; Kim Hung Lo; Jocelyn H Leu; Chyi-Hung Hsu; Elizabeth C Hsia; Zhenhua Xu; Alberto Martini; Daniel J Lovell
Journal:  Rheumatology (Oxford)       Date:  2021-10-02       Impact factor: 7.580
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.